Carmell Therapeutics Corporation (CTCX)

NASDAQ: CTCX · IEX Real-Time Price · USD
2.070
+0.220 (11.89%)
At close: Apr 22, 2024, 12:53 PM
1.910
-0.160 (-7.73%)
After-hours: Apr 22, 2024, 4:04 PM EDT
11.89%
Market Cap 39.84M
Revenue (ttm) n/a
Net Income (ttm) -16.12M
Shares Out 19.25M
EPS (ttm) -1.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,882
Open 1.800
Previous Close 1.850
Day's Range 1.800 - 2.070
52-Week Range 1.700 - 13.310
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date May 11, 2024

About CTCX

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and o... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 9
Stock Exchange NASDAQ
Ticker Symbol CTCX
Full Company Profile

Financial Performance

Financial Statements

News

Carmell Announces Successful Closing of $3.0 Million Private Placement

PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

11 days ago - GlobeNewsWire

Carmell Announces $3.0 Million Private Placement

PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

18 days ago - GlobeNewsWire

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

26 days ago - GlobeNewsWire

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

PITTSBURGH, March 20, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

4 weeks ago - GlobeNewsWire

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

PITTSBURGH, March 18, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced it will host a...

5 weeks ago - GlobeNewsWire

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced that they have ...

2 months ago - GlobeNewsWire

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a human biomaterials company (“Carmell”), today announced the addition of two independent directors to their Board.

5 months ago - GlobeNewsWire

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

FLAGSTAFF, Ariz. , Sept. 12, 2023 /PRNewswire/ -- Moonshot is excited to announce that its incubator client, Axolotl Biologix, based in its NACET Flagstaff, Arizona campus, has finalized a merger with...

7 months ago - PRNewsWire

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion of post-merger integration with Flagstaff-bas...

8 months ago - GlobeNewsWire

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

PITTSBURGH & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company today announced the successful closing of the previously announced merger wi...

9 months ago - Business Wire

Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company

PITTSBURGH & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Carmell Therapeutics Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative medicine company today announced the execution of a definitive agreement and...

9 months ago - Business Wire

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

NEW YORK & PITTSBURGH--(BUSINESS WIRE)--Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful co...

10 months ago - Business Wire

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

NEW YORK--(BUSINESS WIRE)--Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding...

10 months ago - Business Wire